1. Home
  2. SABS vs TOMZ Comparison

SABS vs TOMZ Comparison

Compare SABS & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • TOMZ
  • Stock Information
  • Founded
  • SABS 2014
  • TOMZ 1979
  • Country
  • SABS United States
  • TOMZ United States
  • Employees
  • SABS N/A
  • TOMZ N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • TOMZ Diversified Commercial Services
  • Sector
  • SABS Health Care
  • TOMZ Finance
  • Exchange
  • SABS Nasdaq
  • TOMZ Nasdaq
  • Market Cap
  • SABS 19.0M
  • TOMZ 20.2M
  • IPO Year
  • SABS N/A
  • TOMZ N/A
  • Fundamental
  • Price
  • SABS $1.20
  • TOMZ $0.81
  • Analyst Decision
  • SABS Strong Buy
  • TOMZ Strong Buy
  • Analyst Count
  • SABS 5
  • TOMZ 1
  • Target Price
  • SABS $11.40
  • TOMZ $3.50
  • AVG Volume (30 Days)
  • SABS 37.2K
  • TOMZ 181.7K
  • Earning Date
  • SABS 05-19-2025
  • TOMZ 05-14-2025
  • Dividend Yield
  • SABS N/A
  • TOMZ N/A
  • EPS Growth
  • SABS N/A
  • TOMZ N/A
  • EPS
  • SABS N/A
  • TOMZ N/A
  • Revenue
  • SABS $1,322,410.00
  • TOMZ $8,197,404.00
  • Revenue This Year
  • SABS N/A
  • TOMZ $40.32
  • Revenue Next Year
  • SABS $25.00
  • TOMZ $38.17
  • P/E Ratio
  • SABS N/A
  • TOMZ N/A
  • Revenue Growth
  • SABS N/A
  • TOMZ N/A
  • 52 Week Low
  • SABS $1.11
  • TOMZ $0.52
  • 52 Week High
  • SABS $5.01
  • TOMZ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • SABS 33.63
  • TOMZ 41.41
  • Support Level
  • SABS $1.53
  • TOMZ $0.78
  • Resistance Level
  • SABS $1.80
  • TOMZ $0.87
  • Average True Range (ATR)
  • SABS 0.15
  • TOMZ 0.07
  • MACD
  • SABS 0.02
  • TOMZ 0.00
  • Stochastic Oscillator
  • SABS 0.00
  • TOMZ 31.82

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.

Share on Social Networks: